← 返回事件
持续讨论商业

U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast

图:Fortune

发生了什么

"The growth is mainly due to Novo’s sales and production in the U.S. market at the beginning of this year."

摘要按规则整理自下方来源原文

来源